お見積

サンプルお申込み

お問い合わせ

今すぐ購入

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

本報告書は中枢神経系の治療市場規模の世界市場の概要を紹介します。2019~2023年の歴史的な市場収益データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。レポートは中枢神経系の治療の主要メーカーを詳細に分析し、地域別・国別の収益プロフィールを明らかにしています。 本レポートでは特に、主要地域/国別のセグメントとサブセグメントについて、将来の市場ポテンシャルの探索と予測に焦点を当てています。 複数の地域にわたる包括的なデータと市場価値分析により、読者は包括的かつ詳細な市場洞察を得ることができます。

世界の中枢神経系の治療市場の主な参加者である企業概要、収益、粗利益率、ポートフォリオ、地理的位置、重要な発展について、次のパラメータに基づいて説明します。レポートは中枢神経系の治療のメーカー、地域、種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、タイプとアプリケーション/端末業界別に中枢神経系の治療市場を分類しています。本研究に含まれる主な企業は：Pfizer、Biogen、Johnson & Johnson、Eli Lilly、Otsuka America Pharmaceutical、Merck、Astrazeneca、Novartis、Teva Pharmaceutical Industries、Takeda

地域別市場区分、地域別分析は以下の通り：
    アメリカとカナダ
    中国
    アジア
    ヨーロッパ
    中東、アフリカ、ラテンアメリカ

タイプ別市場セグメント：
    Neurovascular
    Trauma
    Mental Health
    Degenerative Disorder
    Infections
    Cancer

用途別の市場セグメント：
    Clinical Application
    Others

本レポートの詳細内容
世界の中枢神経系の治療市場の現状と将来について、グローバルの主要地域を中心に包括的に分析しています。 当レポートでは、多角的な分析を通じて、市場プレイヤー、地域分布、中枢神経系の治療タイプ、最終用途アプリケーションなどの主要分野を掘り下げ、読者に包括的な市場洞察を提供しています。 レポートは主要企業の中枢神経系の治療収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界の中枢神経系の治療市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。また、当レポートでは、世界市場の主要プレイヤーを特定し、プロファイルを作成するとともに、中枢神経系の治療市場を綿密に分類・応用することで、読者が市場構造とダイナミクスをより正確に把握できるようにし、十分な情報に基づいた意思決定と戦略立案に強力なサポートを提供しています。

中枢神経系の治療のレポートは2019年から2030年までのタイプ別およびアプリケーション別、収益、成長率別のセグメントデータを分析します。収益、予測成長傾向、アプリケーション、およびエンドユーザー業界の市場規模を評価および予測します。

章の概要
第1章：中枢神経系の治療のレポートの報告範囲、各セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメント（製品タイプ、用途など）のエグゼクティブサマリーを紹介します。市場の現状と、短期から中期、および長期的な進化の可能性をハイレベルに見ることができます。（2019～2030）
第2章：中枢神経系の治療の世界及び地域レベルでの売上高。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界各国の市場発展、今後の発展展望、市場空間、生産能力などを紹介する。また、市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界企業が直面する課題とリスク、業界の関連政策の分析などを紹介しています。（2019～2030）
第3章中枢神経系の治療企業の競争状況、収益、市場シェアと業界ランキング、最新の開発計画、合併・買収情報などの詳細分析。（2019～2030）
第4章：各市場セグメントの収益と開発の可能性をカバーし、種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2019～2024）
第5章：中枢神経系の治療の各市場セグメントの収益と開発の可能性をカバーするアプリケーション別のさまざまな市場セグメントの分析を提供し、読者がさまざまな下流市場でブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第6章：北米（米国、カナダ）のタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第7章：ヨーロッパのタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第8章：中国の種類別、および用途別、各セグメントの収益。（2019～2030）
第9章アジア（中国を除く）の種類別、用途別、地域別、セグメントごとの収益。（2019～2030）
第10章：中東、アフリカ、ラテンアメリカの種類別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第11章：中枢神経系の治療の主要企業の概要を提供し、製品の説明と仕様、中枢神経系の治療の収益、粗利益率、最近の展開など、市場の主要企業の基本状況を詳細に紹介します。（2019～2024）
第12章：アナリストの見解/結論

A central nervous system (CNS) disease can affect either the brain or the spinal cord which leads to neurological or psychiatric disorders.

Market Analysis and Insights: Global Central Nervous System (CNS) Therapeutic Market
The global Central Nervous System (CNS) Therapeutic market is projected to grow from US$ 76830 million in 2024 to US$ 93600 million by 2030, at a Compound Annual Growth Rate (CAGR) of 3.3% during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Central Nervous System (CNS) Therapeutic market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030. 
This report researches the key producers of Central Nervous System (CNS) Therapeutic, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Central Nervous System (CNS) Therapeutic, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Central Nervous System (CNS) Therapeutic revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Central Nervous System (CNS) Therapeutic market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Central Nervous System (CNS) Therapeutic revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Pfizer, Biogen, Johnson & Johnson, Eli Lilly, Otsuka America Pharmaceutical, Merck, Astrazeneca, Novartis and Teva Pharmaceutical Industries, etc.

Market Segmentation
By Company
    Pfizer
    Biogen
    Johnson & Johnson
    Eli Lilly
    Otsuka America Pharmaceutical
    Merck
    Astrazeneca
    Novartis
    Teva Pharmaceutical Industries
    Takeda

Segment by Type
    Neurovascular
    Trauma
    Mental Health
    Degenerative Disorder
    Infections
    Cancer

Segment by Application
    Clinical Application
    Others

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        UK
        Italy
        Russia
        Nordic Countries
        Rest of Europe
    China
    Asia (excluding China)
        Japan
        South Korea
        China Taiwan
       Southeast Asia
        India
    Latin America, Middle East & Africa
        Brazil
        Mexico
        Turkey
        Israel
        GCC Countries

Chapter Outline
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Central Nervous System (CNS) Therapeutic in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Central Nervous System (CNS) Therapeutic companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Central Nervous System (CNS) Therapeutic revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

List of Tables
    Table 1. Global Central Nervous System (CNS) Therapeutic Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Neurovascular
    Table 3. Key Players of Trauma
    Table 4. Key Players of Mental Health
    Table 5. Key Players of Degenerative Disorder
    Table 6. Key Players of Infections
    Table 7. Key Players of Cancer
    Table 8. Global Central Nervous System (CNS) Therapeutic Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 9. Global Central Nervous System (CNS) Therapeutic Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 10. Global Central Nervous System (CNS) Therapeutic Market Size by Region (2019-2024) & (US$ Million)
    Table 11. Global Central Nervous System (CNS) Therapeutic Market Share by Region (2019-2024)
    Table 12. Global Central Nervous System (CNS) Therapeutic Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 13. Global Central Nervous System (CNS) Therapeutic Market Share by Region (2025-2030)
    Table 14. Central Nervous System (CNS) Therapeutic Market Trends
    Table 15. Central Nervous System (CNS) Therapeutic Market Drivers
    Table 16. Central Nervous System (CNS) Therapeutic Market Challenges
    Table 17. Central Nervous System (CNS) Therapeutic Market Restraints
    Table 18. Global Central Nervous System (CNS) Therapeutic Revenue by Players (2019-2024) & (US$ Million)
    Table 19. Global Central Nervous System (CNS) Therapeutic Revenue Share by Players (2019-2024)
    Table 20. Global Top Central Nervous System (CNS) Therapeutic by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Central Nervous System (CNS) Therapeutic as of 2023)
    Table 21. Global Central Nervous System (CNS) Therapeutic Industry Ranking 2022 VS 2023 VS 2024
    Table 22. Global 5 Largest Players Market Share by Central Nervous System (CNS) Therapeutic Revenue (CR5 and HHI) & (2019-2024)
    Table 23. Global Key Players of Central Nervous System (CNS) Therapeutic, Headquarters and Area Served
    Table 24. Global Key Players of Central Nervous System (CNS) Therapeutic, Product and Application
    Table 25. Global Key Players of Central Nervous System (CNS) Therapeutic, Product and Application
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Central Nervous System (CNS) Therapeutic Market Size by Type (2019-2024) & (US$ Million)
    Table 28. Global Central Nervous System (CNS) Therapeutic Revenue Market Share by Type (2019-2024)
    Table 29. Global Central Nervous System (CNS) Therapeutic Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 30. Global Central Nervous System (CNS) Therapeutic Revenue Market Share by Type (2025-2030)
    Table 31. Global Central Nervous System (CNS) Therapeutic Market Size by Application (2019-2024) & (US$ Million)
    Table 32. Global Central Nervous System (CNS) Therapeutic Revenue Share by Application (2019-2024)
    Table 33. Global Central Nervous System (CNS) Therapeutic Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 34. Global Central Nervous System (CNS) Therapeutic Revenue Share by Application (2025-2030)
    Table 35. North America Central Nervous System (CNS) Therapeutic Market Size by Type (2019-2024) & (US$ Million)
    Table 36. North America Central Nervous System (CNS) Therapeutic Market Size by Type (2025-2030) & (US$ Million)
    Table 37. North America Central Nervous System (CNS) Therapeutic Market Size by Application (2019-2024) & (US$ Million)
    Table 38. North America Central Nervous System (CNS) Therapeutic Market Size by Application (2025-2030) & (US$ Million)
    Table 39. North America Central Nervous System (CNS) Therapeutic Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 40. North America Central Nervous System (CNS) Therapeutic Market Size by Country (2019-2024) & (US$ Million)
    Table 41. North America Central Nervous System (CNS) Therapeutic Market Size by Country (2025-2030) & (US$ Million)
    Table 42. Europe Central Nervous System (CNS) Therapeutic Market Size by Type (2019-2024) & (US$ Million)
    Table 43. Europe Central Nervous System (CNS) Therapeutic Market Size by Type (2025-2030) & (US$ Million)
    Table 44. Europe Central Nervous System (CNS) Therapeutic Market Size by Application (2019-2024) & (US$ Million)
    Table 45. Europe Central Nervous System (CNS) Therapeutic Market Size by Application (2025-2030) & (US$ Million)
    Table 46. Europe Central Nervous System (CNS) Therapeutic Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 47. Europe Central Nervous System (CNS) Therapeutic Market Size by Country (2019-2024) & (US$ Million)
    Table 48. Europe Central Nervous System (CNS) Therapeutic Market Size by Country (2025-2030) & (US$ Million)
    Table 49. China Central Nervous System (CNS) Therapeutic Market Size by Type (2019-2024) & (US$ Million)
    Table 50. China Central Nervous System (CNS) Therapeutic Market Size by Type (2025-2030) & (US$ Million)
    Table 51. China Central Nervous System (CNS) Therapeutic Market Size by Application (2019-2024) & (US$ Million)
    Table 52. China Central Nervous System (CNS) Therapeutic Market Size by Application (2025-2030) & (US$ Million)
    Table 53. Asia Central Nervous System (CNS) Therapeutic Market Size by Type (2019-2024) & (US$ Million)
    Table 54. Asia Central Nervous System (CNS) Therapeutic Market Size by Type (2025-2030) & (US$ Million)
    Table 55. Asia Central Nervous System (CNS) Therapeutic Market Size by Application (2019-2024) & (US$ Million)
    Table 56. Asia Central Nervous System (CNS) Therapeutic Market Size by Application (2025-2030) & (US$ Million)
    Table 57. Asia Central Nervous System (CNS) Therapeutic Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 58. Asia Central Nervous System (CNS) Therapeutic Market Size by Region (2019-2024) & (US$ Million)
    Table 59. Asia Central Nervous System (CNS) Therapeutic Market Size by Region (2025-2030) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Central Nervous System (CNS) Therapeutic Market Size by Type (2019-2024) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Central Nervous System (CNS) Therapeutic Market Size by Type (2025-2030) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Central Nervous System (CNS) Therapeutic Market Size by Application (2019-2024) & (US$ Million)
    Table 63. Middle East, Africa, and Latin America Central Nervous System (CNS) Therapeutic Market Size by Application (2025-2030) & (US$ Million)
    Table 64. Middle East, Africa, and Latin America Central Nervous System (CNS) Therapeutic Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 65. Middle East, Africa, and Latin America Central Nervous System (CNS) Therapeutic Market Size by Country (2019-2024) & (US$ Million)
    Table 66. Middle East, Africa, and Latin America Central Nervous System (CNS) Therapeutic Market Size by Country (2025-2030) & (US$ Million)
    Table 67. Pfizer Company Details
    Table 68. Pfizer Business Overview
    Table 69. Pfizer Central Nervous System (CNS) Therapeutic Product
    Table 70. Pfizer Revenue in Central Nervous System (CNS) Therapeutic Business (2019-2024) & (US$ Million)
    Table 71. Pfizer Recent Developments
    Table 72. Biogen Company Details
    Table 73. Biogen Business Overview
    Table 74. Biogen Central Nervous System (CNS) Therapeutic Product
    Table 75. Biogen Revenue in Central Nervous System (CNS) Therapeutic Business (2019-2024) & (US$ Million)
    Table 76. Biogen Recent Developments
    Table 77. Johnson & Johnson Company Details
    Table 78. Johnson & Johnson Business Overview
    Table 79. Johnson & Johnson Central Nervous System (CNS) Therapeutic Product
    Table 80. Johnson & Johnson Revenue in Central Nervous System (CNS) Therapeutic Business (2019-2024) & (US$ Million)
    Table 81. Johnson & Johnson Recent Developments
    Table 82. Eli Lilly Company Details
    Table 83. Eli Lilly Business Overview
    Table 84. Eli Lilly Central Nervous System (CNS) Therapeutic Product
    Table 85. Eli Lilly Revenue in Central Nervous System (CNS) Therapeutic Business (2019-2024) & (US$ Million)
    Table 86. Eli Lilly Recent Developments
    Table 87. Otsuka America Pharmaceutical Company Details
    Table 88. Otsuka America Pharmaceutical Business Overview
    Table 89. Otsuka America Pharmaceutical Central Nervous System (CNS) Therapeutic Product
    Table 90. Otsuka America Pharmaceutical Revenue in Central Nervous System (CNS) Therapeutic Business (2019-2024) & (US$ Million)
    Table 91. Otsuka America Pharmaceutical Recent Developments
    Table 92. Merck Company Details
    Table 93. Merck Business Overview
    Table 94. Merck Central Nervous System (CNS) Therapeutic Product
    Table 95. Merck Revenue in Central Nervous System (CNS) Therapeutic Business (2019-2024) & (US$ Million)
    Table 96. Merck Recent Developments
    Table 97. Astrazeneca Company Details
    Table 98. Astrazeneca Business Overview
    Table 99. Astrazeneca Central Nervous System (CNS) Therapeutic Product
    Table 100. Astrazeneca Revenue in Central Nervous System (CNS) Therapeutic Business (2019-2024) & (US$ Million)
    Table 101. Astrazeneca Recent Developments
    Table 102. Novartis Company Details
    Table 103. Novartis Business Overview
    Table 104. Novartis Central Nervous System (CNS) Therapeutic Product
    Table 105. Novartis Revenue in Central Nervous System (CNS) Therapeutic Business (2019-2024) & (US$ Million)
    Table 106. Novartis Recent Developments
    Table 107. Teva Pharmaceutical Industries Company Details
    Table 108. Teva Pharmaceutical Industries Business Overview
    Table 109. Teva Pharmaceutical Industries Central Nervous System (CNS) Therapeutic Product
    Table 110. Teva Pharmaceutical Industries Revenue in Central Nervous System (CNS) Therapeutic Business (2019-2024) & (US$ Million)
    Table 111. Teva Pharmaceutical Industries Recent Developments
    Table 112. Takeda Company Details
    Table 113. Takeda Business Overview
    Table 114. Takeda Central Nervous System (CNS) Therapeutic Product
    Table 115. Takeda Revenue in Central Nervous System (CNS) Therapeutic Business (2019-2024) & (US$ Million)
    Table 116. Takeda Recent Developments
    Table 117. Research Programs/Design for This Report
    Table 118. Key Data Information from Secondary Sources
    Table 119. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Central Nervous System (CNS) Therapeutic Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Central Nervous System (CNS) Therapeutic Market Share by Type: 2023 VS 2030
    Figure 3. Neurovascular Features
    Figure 4. Trauma Features
    Figure 5. Mental Health Features
    Figure 6. Degenerative Disorder Features
    Figure 7. Infections Features
    Figure 8. Cancer Features
    Figure 9. Global Central Nervous System (CNS) Therapeutic Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 10. Global Central Nervous System (CNS) Therapeutic Market Share by Application: 2023 VS 2030
    Figure 11. Clinical Application Case Studies
    Figure 12. Others Case Studies
    Figure 13. Central Nervous System (CNS) Therapeutic Report Years Considered
    Figure 14. Global Central Nervous System (CNS) Therapeutic Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 15. Global Central Nervous System (CNS) Therapeutic Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 16. Global Central Nervous System (CNS) Therapeutic Market Share by Region: 2023 VS 2030
    Figure 17. Global Central Nervous System (CNS) Therapeutic Market Share by Players in 2023
    Figure 18. Global Top Central Nervous System (CNS) Therapeutic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Central Nervous System (CNS) Therapeutic as of 2023)
    Figure 19. The Top 10 and 5 Players Market Share by Central Nervous System (CNS) Therapeutic Revenue in 2023
    Figure 20. North America Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 21. North America Central Nervous System (CNS) Therapeutic Market Share by Type (2019-2030)
    Figure 22. North America Central Nervous System (CNS) Therapeutic Market Share by Application (2019-2030)
    Figure 23. North America Central Nervous System (CNS) Therapeutic Market Share by Country (2019-2030)
    Figure 24. United States Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. Canada Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 26. Europe Central Nervous System (CNS) Therapeutic Market Size YoY (2019-2030) & (US$ Million)
    Figure 27. Europe Central Nervous System (CNS) Therapeutic Market Share by Type (2019-2030)
    Figure 28. Europe Central Nervous System (CNS) Therapeutic Market Share by Application (2019-2030)
    Figure 29. Europe Central Nervous System (CNS) Therapeutic Market Share by Country (2019-2030)
    Figure 30. Germany Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. France Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. U.K. Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Italy Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Russia Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. Nordic Countries Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. China Central Nervous System (CNS) Therapeutic Market Size YoY (2019-2030) & (US$ Million)
    Figure 37. China Central Nervous System (CNS) Therapeutic Market Share by Type (2019-2030)
    Figure 38. China Central Nervous System (CNS) Therapeutic Market Share by Application (2019-2030)
    Figure 39. Asia Central Nervous System (CNS) Therapeutic Market Size YoY (2019-2030) & (US$ Million)
    Figure 40. Asia Central Nervous System (CNS) Therapeutic Market Share by Type (2019-2030)
    Figure 41. Asia Central Nervous System (CNS) Therapeutic Market Share by Application (2019-2030)
    Figure 42. Asia Central Nervous System (CNS) Therapeutic Market Share by Region (2019-2030)
    Figure 43. Japan Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. South Korea Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. China Taiwan Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Southeast Asia Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. India Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. Australia Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 49. Middle East, Africa, and Latin America Central Nervous System (CNS) Therapeutic Market Size YoY (2019-2030) & (US$ Million)
    Figure 50. Middle East, Africa, and Latin America Central Nervous System (CNS) Therapeutic Market Share by Type (2019-2030)
    Figure 51. Middle East, Africa, and Latin America Central Nervous System (CNS) Therapeutic Market Share by Application (2019-2030)
    Figure 52. Middle East, Africa, and Latin America Central Nervous System (CNS) Therapeutic Market Share by Country (2019-2030)
    Figure 53. Brazil Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Mexico Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Turkey Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. Saudi Arabia Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. Israel Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 58. GCC Countries Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 59. Pfizer Revenue Growth Rate in Central Nervous System (CNS) Therapeutic Business (2019-2024)
    Figure 60. Biogen Revenue Growth Rate in Central Nervous System (CNS) Therapeutic Business (2019-2024)
    Figure 61. Johnson & Johnson Revenue Growth Rate in Central Nervous System (CNS) Therapeutic Business (2019-2024)
    Figure 62. Eli Lilly Revenue Growth Rate in Central Nervous System (CNS) Therapeutic Business (2019-2024)
    Figure 63. Otsuka America Pharmaceutical Revenue Growth Rate in Central Nervous System (CNS) Therapeutic Business (2019-2024)
    Figure 64. Merck Revenue Growth Rate in Central Nervous System (CNS) Therapeutic Business (2019-2024)
    Figure 65. Astrazeneca Revenue Growth Rate in Central Nervous System (CNS) Therapeutic Business (2019-2024)
    Figure 66. Novartis Revenue Growth Rate in Central Nervous System (CNS) Therapeutic Business (2019-2024)
    Figure 67. Teva Pharmaceutical Industries Revenue Growth Rate in Central Nervous System (CNS) Therapeutic Business (2019-2024)
    Figure 68. Takeda Revenue Growth Rate in Central Nervous System (CNS) Therapeutic Business (2019-2024)
    Figure 69. Bottom-up and Top-down Approaches for This Report
    Figure 70. Data Triangulation
    Figure 71. Key Executives Interviewed